Navigation Links
Acne Drug Prevents Tissue Damage From Emphysema
Date:5/15/2008

Doxycycline in mice boosts protective protein, too early to see benefit in humans

THURSDAY, May 15 (HealthDay News) -- Researchers say they may be able to prevent the tissue damage that lung diseases, such as emphysema, cause by treating the patient with doxycycline, an antibiotic commonly used to treat acne.

In experiments on mice, doxycycline -- which is also used to treat common ailments such as sinusitis and urinary tract infections -- appears to counter low levels of VEGF, a protein that helps to maintain healthy lung tissue but is in unusually low levels in people with emphysema.

"The images that we have of the lungs of mice that have been treated with doxycycline are startlingly different to those that we didn't treat," Ellen C. Breen, from the School of Medicine at the University of California, San Diego, said in a prepared statement. "VEGF-deficient lungs show vast pockets of tissue damage when untreated and greatly reduced damage when treated with doxycycline."

While the experiments show that doxycycline clearly can play a role in preventing lung tissue damage, Breen stressed that it is too early to say whether it could help humans with a genetic predisposition to lung disease.

"It's also important to remember that we were treating the mice with the drug whilst inducing the symptoms of lung disease, so this is by no means a cure," she said.

More information

The U.S. National Library of Medicine has more about emphysema.



-- Kevin McKeever



SOURCE: University of Leeds, news release, May 14, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Reducing intake of dietary fat prevents prostate cancer in mice
2. Calorie restricted diet prevents pancreatic inflammation and cancer
3. Trainor Lab prevents rare birth defect by inactivating p53 gene
4. You can teach an old dog new tricks: anti-malarial prevents cancer in mice
5. Walking prevents bone loss caused from prostate cancer treatment
6. Guided radiation therapy for prostate cancer prevents damage to surrounding organs
7. Researchers at IRB Barcelona discover one of the mechanisms that prevents the spread of colon cancer
8. Weekly dose of osteoporosis drug prevents bone loss after breast cancer treatment
9. 2nd ESMO symposium on soft tissue carcinomas and GIST
10. How embryonic stem cells develop into tissue-specific cells demonstrated
11. Three Million Californians Say Yes! to Organ and Tissue Donation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 05, 2016 , ... BSI and Brenntag Canada have been appointed by Chr. ... of their natural fruits and beverage colorants effective November 1, 2016. ... our Life Sciences product portfolio,” said Steve Brauer, President of Brenntag Specialties, Inc. “Representing ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... Great Point Partners ("GPP") portfolio company, today announced it has acquired the ... TCS was previously a subsidiary of Chiltern International and focuses on ...
(Date:12/5/2016)... ... ... The new knee compression sleeves come as a pair which will provide ... lifting and any sport that requires knee compression or protection from the demands ... higher quality knee sleeve performance. Firstly it is made out of premium 7mm thick ...
(Date:12/5/2016)... OH (PRWEB) , ... December 05, 2016 , ... ... engineering solution called the CardioQuick Patch® significantly improves the reproducibility and accuracy of ... in various healthcare settings. , Over the last 60 years, studies have ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... "Best Surgical Body Shaping" at the 2016 Anti-Aging & Beauty Awards ... , The Aesthetic & Anti-Aging Medicine European Congress (AMEC) brings together ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 ... alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response ... and tolerability profile of ropeginterferon alfa-2b versus HU ... ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing authorization ... present this data to the FDA as it seeks approval ...
(Date:12/4/2016)... SAN DIEGO , Dec. 3, 2016 Johnson ... filed on behalf of purchasers of Zimmer Biomet Holdings, Inc. ... September 7, 2016 through October 31, 2016 (the "Class Period"). ... It designs, manufactures, and markets orthopaedic reconstructive products, such as ... ...
(Date:12/4/2016)... 3, 2016   Pairnomix, LLC, a genetic research ... recognized by the White House, today announced that findings from ... identification of candidate therapies for a patient with epileptic encephalopathy ... were presented at the 70 th Annual Meeting of ... TX , December 2-6, 2016.  Pairnomix, unique ...
Breaking Medicine Technology: